Clinical Edge Journal Scan

High b-value imaging adds no value in prostate cancer detection


 

Key clinical point: No significant difference was noted in high b-value 3.0 T biparametric magnetic resonance with the Simplified Prostate Image Reporting and Data System (S-PI-RADS) compared with standard PI-RADS in biopsy-naïve men.

Major finding: The area under the curve values of these two methods for detecting prostate cancer were 0.905 and 0.892, respectively, and the AUC values for detecting clinically significant prostate cancer were 0.919 and 0.906, respectively.

Study details: The data come from a retrospective study of 224 adult men who underwent prostate cancer biopsy after imaging by two different radiologists, using the multi-parameter magnetic resonance imaging (mp-MRI) with the prostate imaging report and data system version 2 (PI-RADS v2), and biparametric magnetic resonance imaging (bp-MRI) with the simplified prostate image reporting and data system (S-PI-RADS).

Disclosures: The study was supported by Key R & D Project of Hainan Province. The researchers had no financial conflicts to disclose.

Source: Wang G et al. Clin Imaging. 2021 Jun 29. doi: 10.1016/j.clinimag.2021.06.024.

Recommended Reading

TARE beats systemic therapy for survival benefits in hepatocellular carcinoma with major vascular invasion
Federal Practitioner
Statin use shows dose-dependent reduction in the risk of hepatocellular carcinoma in hepatitis B patients
Federal Practitioner
Lenvatinib extends time to disease progression in HCC patients with portal vein tumor thrombus
Federal Practitioner
Anatomical liver resection surpasses nonanatomical resection for overall survival in HCC
Federal Practitioner
Laparoscopic repeat liver resection shows safety for recurrent HCC patients
Federal Practitioner
Liver resection yields limited success in HCC patients with hepatitis B/C coinfection
Federal Practitioner
Clinical Edge Journal Scan Commentary: HCC August 2021
Federal Practitioner
IBD patients with prostate cancer may benefit from radiation therapy
Federal Practitioner
Platelet-to-lymphocyte ratio fails to predict prostate cancer at biopsy
Federal Practitioner
Active surveillance does not impair quality of life in low-risk prostate cancer
Federal Practitioner